benzotriazole has been researched along with Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Alozie, CO; Casas, S; De Castro, M; DeRose, NK; Dominguez, D; Elshaer, MR; Garton, CS; Gucwa, AL; Lehr, AL; Padilla, AD; Turbi-Henderson, ML; Twining, SD | 1 |
Hassan, RA; Kassab, AE | 1 |
He, LQ; Jiang, AQ; Liu, ZJ; Luo, Y; Yang, YH; Zhang, S; Zhu, HL | 1 |
3 other study(ies) available for benzotriazole and Neoplasms
Article | Year |
---|---|
Synthesis and Antiproliferative Evaluation of 2-Deoxy-
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; HeLa Cells; Humans; Imidazoles; Neoplasms; Temperature; Triazoles | 2021 |
Novel benzotriazole N-acylarylhydrazone hybrids: Design, synthesis, anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis and FAK inhibition.
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Design; Drug Screening Assays, Antitumor; Focal Adhesion Protein-Tyrosine Kinases; Humans; Hydrazones; Molecular Docking Simulation; Neoplasms; Triazoles | 2018 |
Synthesis, biological evaluation, and molecular docking studies of novel 1,3,4-oxadiazole derivatives possessing benzotriazole moiety as FAK inhibitors with anticancer activity.
Topics: Antineoplastic Agents; Focal Adhesion Protein-Tyrosine Kinases; HT29 Cells; Humans; MCF-7 Cells; Molecular Docking Simulation; Neoplasms; Oxadiazoles; Protein Kinase Inhibitors; Structure-Activity Relationship; Triazoles | 2013 |